Newsletters - August 2000

Newsletters - August 2000

Bacopa monniera (syn. Herpestis monniera), commonly known as Brahmi, has been used by Ayurvedic practitioners in India since ancient times for the management of mental conditions.1 In clinical studies, Bacopa monniera, has been shown to be a useful agent for renovating and revitalizing components of intellectual behavior in children.2 In adults, Bacopa monniera has been reported to be effective in reducing anxiety levels, thereby improving brain functions in terms of memory enhancement and elevated mental performance.3

In a recent preclinical study4, researchers revealed that Bacopa monniera possesses significant antioxidant activity that may be responsible for its memory enhancement and mental activity properties.

Bhattacharya, S.K. et al.4, the researchers of the study, investigated the effects of a standardized extract of Bacopa monniera and Deprenyl, the conventional medicine used in the treatment of cerebral conditions such as Parkinson’s disease, dementia, and depression, on different regions of the rat brain (frontal, cortical, striatal, and hippocampal).

Bacopa monniera exhibited a significant antioxidant effect and increased the levels of the antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX), in all the regions of the rat brain. Since these enzymes form the first line of defense against oxidative damage to the cells, the authors inferred that the cognition-facilitating action of Bacopa monniera may be attributed at least in part to free radical scavenging activity. In contrast, Deprenyl induced an increase of all antioxidant enzymes in all regions of the brain except the hippocampus, the part of the brain where all memories are created.

Sources:

  1. Nadkarni, A.K. (ed.) (1991) Dr. K. M. Nadkarni’s Indian Materia Medica. Popular Prakashan Private Ltd.: Bombay, India. pgs. 624-625.
  2. Sharma, R., Chaturvedi, C., and Tewari, P.V. (1987) Efficacy of Bacopa monnieri in revitalizing intellectual functions in children. J. Res. Edu. Ind. Med. Jan-June, 1-10.
  3. Singh, R.H. and Singh, L. (1980) Studies on the anti-anxiety effect of the Medhya Rasayana Drug, Brahmi (Bacopa monniera Wettst.)-Part 1. J. Res. Ayur. Siddha, 1, 133-148.
  4. Bhattacharya, S.K., Bhattacharya, A., Kumar, A., and Ghosal, S. (2000) Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytotherapy Research, 14(3), 174-179.

Sabinsa Corporation supplies Bacopin®, Sabinsa’s proprietary Bacopa monniera extract standardized for a minimum of 20% Bacosides, the active principles responsible for improving memory-related functions.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.